Pegylated integrated interferon mutant - Beijing Tri-Prime Genetic EngineeringAlternative Names: PEG-IIFNm
Latest Information Update: 13 Apr 2016
At a glance
- Originator Beijing Tri-Prime Genetic Engineering
- Class Antivirals; Interferons
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Hepatitis B; Hepatitis C